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ABSTRACT
COMPARATIVE ANALYSIS OF ANTIVIRAL RESPONSES IN MOUSE
EMBRYONIC STEM CELLS AND IN MESENCHYMAL STEM CELLS
by Jundi Wang
August 2013
Embryonic stem cells (ESCs) are cells that have unlimited capacity for selfrenewal and differentiation. These properties make ESCs a great cell source for
application in regenerative medicine. When used for cell therapy, ESC-derived cells
could be placed in a wounded area that is likely to be exposed to various pathogens.
However, it is not well-understood whether ESCs and ESC-derived cells have active
antiviral responses against infectious agents from the environment. To answer this
important question, I comparatively analyzed the antiviral responses of ESCs and
mesenchymal stem cells (MSCs, C3H10Tl/2 cell line) to infectious agents. Using the
expression of type I interferon (IFN) as a benchmark of antiviral responses, our results
indicated that the type I IFN were robustly induced in C3Hl0Tl/2 cells, but not in ESCs,
when they were exposed to polyinosinic:polycytidylic acid (poly(I:C), a dsRNA viral
analog) and La Crosse Virus (LACV). Our results also showed that TLR3, RIG! and
MDA5, the receptors for viral RNA, are expressed at lower levels in mouse ESCs
(mESCs) than in C3H10Tl/2 cells. However, mESCs are susceptible to LACV infection
resulting in cell death, which can be reduced by IFNP pretreatment. Furthermore, IFNP
induced expression of ISG 15, PKR and dsRNA receptor genes that play key roles in
antiviral responses. In conclusion, mESCs are deficient in type I IFN expression, but
they have functional mechanisms that mediate the antiviral effects of type I IFN.
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CHAPTER I
INTRODUCTION
Embryonic Stem Cell
Embryonic stem cells (ESCs) have been intensively studied for the past several
years due to their pluripotency and self-renewal capacity (Wobus & Boheler, 2005;
Keller, 2005). Pluripotency is a unique property of ESCs that allows them to differentiate
into any of the three germ layer cells. Therefore, ESCs are considered a promising cell
source for regenerative medicine. ESCs are derived from an early developmental stage of
the embryo called a blastocyst, which consists of outer trophoblast cells surrounding the
inner cell mass (ICM). The ICM is composed of undifferentiated cells with the ability to
form the three primary germ layers (endoderm, mesoderm and ectoderm), which will
further differentiate to all tissues and organs (Fig. 1).
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Figure 1. ESCs and Their Differentiation Potential (Wobus & Boheler, 2005)

2

Maintenance of pluripotency without further differentiation is necessary for the
study of ESCs. Under in vitro culture conditions, ESCs require leukemia inhibitory factor
(LIF) which prevents ESCs differentiation by binding to heterodimeric receptors and
results in the activation of the JAK/STAT (Janus kinase-signal transducer and activator of
transcription) pathway, which is essential and sufficient to maintain the pluripotency of
ESCs (Niwa, 2007). Pluripotency refers to the capacity of ESC differentiating to different
cell lineages (Wobus & Boheler, 2005; Keller, 2005). In the absence LIF, ESCs can
differentiate into specialized cell types such as dendritic cells, cardiomyocytes,
endothelial cells, neurons, smooth muscle cells and hepatocytes if proper conditions are
provided (Ying, Stavridis, Griffiths, Li & Smith, 2003; Maltsev, Wobus, Rohwedel,
Bader, & Hescheler, 1994; Risau et al, 1988; Lee, Lumelsky, Studer, Auerbach, & Mc
2000; Drab et al, 1997; Jones, Tosh, Wilson, Lindsay, & Forrester, 2002; Fairchild et al,
2000). Self-renewal is defined as the ability of ESCs to divide indefinitely while
maintaining pluripotency (He, Nakada, & Morrison, 2009). It is well established that the
self-renewal and pluripotency in ESCs are mainly regulated by a set of transcriptional
factors, including Oct4, Sox2 and Nanog. The Oct4-Sox2-Nanog transcriptional
regulatory network forms a positive feedback loop which allows these transcription
factors to regulate each other by binding to anyone of their promoter regions, and
negatively regulates the expression of differentiation promoting genes (Smith, 2001).
Moreover, it has been reported that Oct4 and activated JAK/STAT3 pathway can
cooperatively induce Kruppel-like factors such as klf 2, 4, and 5 to maintain ESC selfrenewal (Pinney & Emerson, 1989). Therefore, Oct4, Nanog and Sox2 play the most
important roles in maintain the properties of ESCs.
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The self-renewal capacity and pluripotency give ESCs great potential in the field
of regenerative medicine. Many studies have reported that ESCs-derived cells have the
potential to treat human diseases, such as neurodegeneration, diabetes, and myocardial
infarction (Svendsen & Smith, 1999; Soria et al, 2000; Klug, Soonpaa, Koh, & Field
1996). However, there are many obstacles still need to be overcome before ESCs are used
as a source of cell based therapy. For example, it is known that self-renewal of
undifferentiated ESCs can result in the development of teratomas if unpurified ESCderived cells are transplanted into the patient (Keller, 2005). Furthermore, the issue of
immunological rejection needs to be resolved, as it will cause the destruction of
transplanted cells via activation of the recipient's immune system. Antiviral responses
have been extensively studied in other types of cells, but whether or not ESCs and ESCderived cells have any functional innate immunity has not been investigated. Since ESCs
are normally residing in a sterile environment of the womb, they may not be exposed to
pathogens from the outside environment during the early stage of development (Levy,
2007). However, for purposes of clinical application, ESCs must be differentiated and
purified in vitro before being transplanted into patients. After transplantation, these cells
will be potentially challenged by the infectious agents ; therefore, the capacity of innate
immunity is critical for the functionality and survival of implanted cells. As already
suggested by previous studies, human ESCs (hESCs) and hESC-derived endothelial cells
do not have mature immune function (Foldes et al., 2010; Chen, Yang, & Carmichael,
2010). The molecular basis of the innate immunity deficiency in ESCs has not yet been
studied in details. The objective of this project is to investigate the antiviral responses as
a critical part of innate immunity in mouse ESCs (mESCs).
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Mesenchyrnal Stern Cells
Compared with ESCs, MSCs are more differentiated stern cells which can
respond to different infectious agents. MSCs are adult stern cells with limited capacity of
self-renewal and differentiation to closely related cell lineages (Williams & Hare, 2011).
They were initially isolated from the bone marrow strorna, which have the potential to
differentiate into rnesoderrn-derived cells, such as osteoblasts, chondrocytes, adipocytes,
and rnyotubes (Williams & Hare, 2011 ; Minguell, Erices, & Conget, 2001). It is now
known that MSCs exist in different tissues, such as umbilical cord blood, adipose tissue,
and epithelial tissues (Ren et al., 2012; Lee et al., 2004; Jiang et al., 2002). Therefore,
MSCs are also regarded as promising source of cell-based therapy for a wide range of
degenerative diseases.
The C3H lOTl/2 cells were established in 1973 from 14- to 17-day old C3H
mouse embryos. These cells display fibroblastic morphology in cell culture and are
functionally similar to MSCs that can differentiate several cell types, such as adipocytes,
pericytes/srnooth muscle cells, and endothelial cells (Proweller, Pear, & Parrnacek, 2005;
Pinney & Emerson, 1989; Wang et al., 2010; Tang, Otto, & Lane, 2004). In this project,
C3H lOTl/2 cells, a well-characterized MSC line that are highly responsive to different
infectious agents (Wang et al., 2013), will be used for comparative analysis of the innate
immunity in rnESCs.
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Antiviral Responses
Antiviral response is a critical component of innate immunity and plays very
important roles against viral infections. Innate immunity and adaptive immunity are two
components of the immune system. Innate immunity is the first line of an organism's
defense against infectious agents. The innate immunity system is composed of
mechanical, chemical and cellular elements. In mechanical element, the physical barrier,
such as epidermis and mucosa, protects the organism from pathogens invasion. The
chemical element is divided into three components: pathogen recognition, proteins or
peptides-mediated microbe hydrolysis, and cytokines and chemokines that orchestrate the
immune response. The third element is the cellular element, which includes epithelial
cells, mast cells, dendritic cells, NK cells and phagocytic cells. These cells form a
complicate antiviral network to protect organisms from infectious agents by different
mechanisms (Basset, Holton, O'Mahony, & Roitt, 2003). In this project, we will focus on
the study of antiviral responses in ESCs and MSCs.
It was well-established that innate immunity plays an important role in the

pathogen-recognition and subsequent signaling transduction to protect cells from
pathogenic attacks (Medzhitov & Janeway, 2000). Innate immunity can immediately
respond to invading pathogens by recognizing conserved structures termed pathogenassociated molecular patterns (PAMPs) (Mogensen, 2009). During early innate immune
activation, these PAMPs will be detected by pattern-recognition receptors (PRRs),
proteins expressed on the cell surface or in the cytosol. After PRR activation, the
downstream signaling pathways are triggered by activating a multitude of transcription
factors, such as interferon regulatory factors (IRFs) and nuclear factor-KB (NF-KB),
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which coordinately regulate the expression of type I interferon (IFN) and cytokines
(Alcira, Uematsu, & Takeuchi, 2006). Through paracrine and autocrine signaling, IFNs
and cytokines participate in different aspects of innate immune as well as adaptive
immune responses (Mogensen, 2009).
The members of toll-like receptors (TLRs) family are the major class of PRRs and
are expressed on the cell surface or the membranes of endosomes in most cell types
(Miettinen, Sareneva, Julkunen, & Matikainen, 2001). TLRs are composed of an
extracellular ligand-binding domain, which recognizes and binds to the conserved
structures of pathogens, and a cytoplasmic Toll/interleukin-1 receptor homology (TIR)
domain that plays an important role in signal transduction (Carty & Bowie, 2010). After a
ligand binds to TLRs, adaptor molecules are recruited to the cytoplasmic domain of TLRs
and trigger downstream signal pathways (Mogensen, 2009). So far, 10 members of the
TLR family have been identified in mice (designated TLRl through TLRlO). TLRl, 2, 4,
5, 6, and 10 mainly detect bacterial components (Mogensen, 2009; Jin et al., 2007; Kim
et al., 2007). The rest of the TLRs (TLR3, 7, 8, and 9) mainly recognize nucleic acids
(Liu et al., 2008; Kawai & Alcira, 2008).
The Retinoic Acid-Inducible Gene-I-like receptors (RLR) are another family of
PRRs. All RLR members are expressed in the cytoplasm. Retinoic Acid-Inducible Gene-I
(RIG-I), Melanoma Differentiation-Associated Gene 5 (MDA5), and Laboratory of
Genetics and Physiology 2 (LGP2) are the members of the RLR family. Although aH of
these receptors can detect dsRNA, RIG-I preferentially detects short dsRNA and MDA5
mainly binds to long dsRNA (Kato et al, 2008; Pippig et al, 2009). The structure of RLRs
consists of a DExH/D (Asp-Glu-X-His/Asp)-box RNA helicase domain and a C-terminal
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domain (Mogensen, 2009; Matsumiya & Stafforini, 2010). Two Caspase Activation and
Recruitment Domains (CARDs) are located at the N-termini of RIG-I and MDA5, but
LGP2 lacks a CARD domain (Yoneyama & Fujita, 2007). In the inactivated
conformation, the C-terminal domain of RLR prevents CARDs from binding to the
downstream adaptor molecules until RLR binds to viral dsRNA (Matsumiya & Stafforini,
2010; Yoneyama & Fujita, 2007; Saito et al., 2007). The binding of dsRNA to the Cterminal domains results in conformational change in C-terminal domain of RIG-I or
MDA5. Then, the CARDs will be released and binds to the adaptor protein such as IFN~
promoter stimulator 1 (IPS-1) at the mitochondrial membrane to ultimately activate
transcription factors that lead to the antiviral response (Matsumiya & Stafforini, 2010).
Double stranded RNA-activated protein kinase (PKR) is composed of two
functional domains, an N-terminal dsRNA binding domain (dsRBD) and a C-terminal
kinase domain containing the major phosphorylation site (Nallagatla, Toroney, &
Bevilacqua, 2011). It plays important roles in antiviral response. The viral dsRNA is
recognized by the dsRNA binding motifs (dsRBM) located at N-terminal dsRBD via
minor groove interactions. The binding of viral dsRNA causes conformational changes in
PKR and leads to autophosphorylation and dimerization. In addition to selectively
activating the transcription of genes involved in the immune responses, PKR also causes
a general inhibition of transcription, translation and host cell proliferation that limit viral
replication (Mogensen, 2009). Table 1 lists the major microbial components and PRRs.
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Table 1

Recognition of Microbial Components by PRRs
Receptor

Cellular
Localization

PRR-Recognized Microbial
Com2onent(s)

Species of
Microorganism(s)

Cell surface

Triacyl lipopeptides

Bacteria

Cell surface

Diacyl Lipopeptides

Mycoplasma

Lipoteichoic acid

Gram-positive
Bacteria
Various pathogens
Gram-positive and
negative bacteria
Mycobacteria
Neisseria
Viruses
Protozoa
Candida
Fungi
Fungi
Viruses

TLRs

TLRJITLR2
TLR2/TLR6

TLR2

TLR3
TLR4

TLR5
TLR7/8
TLR9

Cell surface

Cell surface
Endosomes
Cell surface

Cell surface
Endosome
Endosome

RLRs
RIG-I

Cytoplasm

MDA5

Cytoplasm

Miscellaneo
us
PKR

Cytoplasm

Lipoprotein
Peptidogl ycan
Lipoarabinomannan
Porins
Envelope glycoproteins
GPI-mucin
Phospholipomannan
Zymosan
~-Glycan
dsRNA

LPS
Envelope gl ycoproteins
Glycoinositolphospholipids
Mannan
HSP70
Flagellin
ssRNA
CpGDNA

Gram-negative
bacteria
Viruses
Protozoa
Candida
Host
Flagellated bacteria
RNA viruses
Viruses, bacteria,
protozoa

dsRNA (short),
5' -triphosphate RNA
dsRNA (long)

Viruses

dsRNA,
5' -triehosehate RNA

Viruses

Viruses
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After PRRs bind to their ligands, a number of different signaling pathways are
activated depending on the binding of different sets of adaptor molecules. As shown in
Figure. 2. In TLR-induced signaling pathways, ligand binding induces TLR dimerization
and binding of adaptor molecules to the cytoplasmic TIR domain, such as Myeloid
differentiation factor 88 (MyD88) or TIR-domain-containing adapter-inducing IFN~
(TRIP) following the binding of a ligand (Mogensen, 2009). MyD88 and TRIP are
involved in regulating inflammatory genes and type I IFN expression. In the case of the
signaling pathway mediated by TLRl, 2, 4, 5, 6, 7, 8, and 9, MyD88 binds to the TIR
domain of the TLR and phosphorylates Interleukin-1 receptor-associated kinase (IRAK)
and transforming growth factor-activated protein kinase 1 (TAKl), causing the activation
of either the NF-KB or MAPK pathway (Mogensen, 2009; Bums et al., 1998). On the
other hand, TRIP plays essential roles in TLR3 mediated antiviral pathway. The
recognition of viral dsRNA by TLR3 recruits TRIP to the receptor. It was reported that
the binding of TLR4 and bacterial component can also trigger TRIP-mediated
downstream pathway. Then, TRIP binds to TNFR-associated factor 6 (TRAF6) and
receptor-interacting protein 1 (RIP1) and ultimately activates the NF-KB and IRF3/7
pathway (Akira et al., 2006).
In the RLR mediated signaling pathway, dsRNA binding triggers signaling via
CARD-CARD interaction between the receptor and the adaptor protein IPS-1
(Matsumiya & Stafforini, 2010). Then, the TNF receptor-associated death domain
(TRADD) recruits to IPS-1 and forms IPS-1-TRADD complex (Michallet, 2008), which
eventually phosphorylates IRF3 and IRF7 through the activation of TANK-binding

10
kinase 1 (TBKl) / I-K13 kinase c (IKKc) (Takahashi et al, 2006), which leads to the
expression of type I IFN and cytokines.
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Figure 2. The Signaling Pathways Involved in Innate Immunity (Mogensen, 2009).

Type I IFN (IFNa and IFN~) gene expression is mainly mediated by PRR
signaling pathways via activation of IRF3 and IRF7 (IRF3/7) (Akira et al., 2006;
Yoneyama et al., 1998). As shown in Figure 3, IFNa and IFN~ are secreted into the
surrounding tissue. Depending on the state of the cell, they affect different physiological
events via autocrine and paracrine signaling mechanisms. In normal cells, type I IFN
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have been demonstrated to play important roles in inhibiting viral replication (Siren,
Pirhonen, Julkunen, & Matikainen, 2005). On the other hand, type I IFN may cause the
death of the infected cells as a mechanism of antiviral response (Takaoka & Yanai,
2006). Although type I IFN are best known for their antiviral activities, they also regulate
several other cellular activities, such as cell differentiation (Boo & Yang, 2010; Clemens
& McNurlan, 1985) .
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Figure 3. The Overview of the Signaling Network for Type I IFN in Innate Immunity
(Takaoka & Yanai, 2006).
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Signaling Pathway Activated by Type I Interferon
As mentioned above, the PRR-mediated antiviral pathways can activate NF-KB
and IRF3/7, and induce expression of type I IFN. Once secreted, IFN bind the interferonalpha/beta receptor (IFNAR) (Boo & Yang, 2010), which recruits and activates JAK and
leading to STATl and STAT2 phosphorylation (De et al., 2001). The phosphorylated
STATl and STAT2 translocate into the nucleus and induced the expression of numerous
genes, known as interferon-stimulated genes (ISGs). The best studied ISGs include Mx
proteins, PKR, and 2',5'oligoadenylate, which play key roles in antiviral responses.
Mx proteins are a small family of GTPases. A unique property of Mx GTPases is
their antiviral activity against a wide range of RNA viruses, such as Influenza and some
members of the Bunyavirus family (Haller, Staeheli, & Kochs, 2007). GTP-binding and
carboxy-terminal effector functions of Mx protein play important roles in recognizing
viral nucleocapsid-like structures. Eventually, these viral nucleocapsid proteins are
trapped and sorted into locations where they become unavailable for the generation of
new virus particles (Haller & Kochs, 2002). As previously mentioned, activated PKR
phosphorylates eukaryotic initiation factor 2 alpha (eIF2a) and blocks viral gene
translation via protein synthesis inhibition (Nallagatla et al., 2011). Whereas,
2',5'oligoadenylate activates RNase L that causes degradation of viral RNA thereby
inhibiting viral replication (Boo & Yang, 2010; Li, Blackford, & Hassel, 1998).
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CHAPTER II
OBJECTIVE AND SIGNIFICANCE
ESCs have attracted enormous attention in recent years with the expectation that
they could be used as a source for cell-based therapy. While the benefit of research on
ESCs in medical applications is exciting, currently there is limited understanding of the
basic physiology of ESCs and their derived cells. When used for cell therapy, ESCderived cells would be placed in a wounded area that is likely to be exposed to various
pathogens. Therefore, their fate and functionality may depend on their innate antiviral
responses to deal with a hostile environment. Innate immunity as the first line of defense
has been intensively investigated in a wide variety of somatic cells. It is generally
believed that most cell types, if not all, have acquired innate immunity. However, recent
studies indicated that ESCs do not respond to a wide range of infectious agents including
bacterial LPS and dsRNA (Foldes et al., 2010; Chen et al, 2010). Our recent study
demonstrated mESCs are unable to express type I IFN when exposed to viral infections,
indicating that they do not have functional antiviral mechanisms (Wang et al., 2013).
Surprisingly, we recently found that ESCs are able to respond to IFN~ and express the
genes that confer antiviral activities. However, the molecular mechanisms involved have
not been elucidated. The proposed study aims to understand the antiviral responses of
ESCs and how they are affected by the antiviral effect of IFN. This study may open up an
important area in ESC research for understanding the development of antiviral
mechanisms during embryogenesis and how the immunogenic signals affects ESC
physiology. The findings from this study could provide valuable information to prepare
ESC-derived cells for their application in regenerative medicine.
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CHAPTER III
METHODS
Cell Culture
mESCs (D3 cell line) were obtained from ATCC. They are used for the majority
of the experiments in this study and maintained in Dulbecco's modification of Eagles's
medium (DMEM) (Mediatech, Inc., Manassas, VA) containing 15% fetal bovine serum
(FBS) (ATLANTA biological, Lawrenceville, GA) with leukemia inhibitory factor (LIF)
(EMD Millipore Corporation, Billerica, MA) and 100 unit/mL penicillin and 100 µg/mL
streptomycin. They were routinely maintained in cell culture dishes coated with 0.1 %
gelatin. C3H10Tl/2 cells were cultured in minimum essential medium (MEM)
(Mediatech, Inc., Manassas, VA) containing 10% FBS and antibiotics at the
concentrations mentioned above. All cells were maintained at 37 °Cina humidified
incubator with 5% CO2.
Cell Treatment
D3 and C3H10Tl/2 cells were plated at -40% and -70% confluence,
respectively, and cultured for 24 h before the experiments. Poly(I:C) (Sigma-Aldrich, St.
Louis, MO) was transfected into the cells with DharmaFECT reagent (Thermo Scientific,
West Palm Beach, FL). For poly(l:C) transfection experiments, control cells were
transfected with DharmaFECT reagent only. For viral infection, LACY (a gift from Dr.
Fengwei Bai, The University of Southern Mississippi) viral stocks were added to the cell
culture at the concentrations as specified in individual experiments. The culture medium
and treated cells were collected at different time periods and used for various analyses.
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Spectrophotometric Analysis of Cell Viability
Cell viability was determined by colony size and by cell number after toluidine
blue (TB) staining. The cells treated with poly(l:C) were fixed with methanol for 15
minutes. The cells collected from the live virus infection experiments were treated with
2% paraformaldehyde (PFA) first for virus inactivation. After PFA treatment, the cells
were similarly fixed with methanol for 15 minutes. The cells were stained with TB for 30
minutes after phosphate buffered saline (PBS) (Thermo Scientific, West Palm Beach, FL)
washing. After 30 min incubation, the cells were washed with water and air-dried,
followed by using 2% sodium dodecyl sulfate (SDS) to extract the TB. OD630 value was
measured by a Bio-Tek Instruments ELX800 microplate reader and analyzed with KC
junior software (Bio-Tek Instruments, Inc, Winooski, VT).
R~al-Time Quantitative Polymerase Chain Reaction (RT-qPCR)
Total RNA was extracted using Tri-reagent (Sigma-Aldrich, St. Louis, MO).
cDNA was prepared by M-MLV reverse transcriptase (Promega, Madison, WI). RTqPCR was performed using SYBR green ready mix (Bio-Rad; Hercules, CA) on a
MX3000PTM RT-PCR system (Stratagene, La Jolla, CA). The mRNA level from RTqPCR was calculated using the t1t1Ct method (Pfaffl, 2001).13-actin mRNA was used as a
calibrator for the calculation of relative mRNA of the tested genes. Sequences of genespecific primers are listed in Table 2.
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Table 2

Sequences of Gene-specific Primers

Gene

Forward Primer

Reverse Primer

IL-6

TAGTCCTfCCfACCCCAATITCC

TfGGTCCTfAGCCACTCCTfC

IFN~

CCCTATGGAGATGACGGAGA

ACCCAGTGCTGGAGAAATfG

IFNa

CTGCTGGCTGTGAGGACATA

AGGAAGAGAGGGCTCTCCAG

RIG-I

ATfCAGGAAGAGCCAGAGTGTC

GTCTfCAATGATGTGCfGCAC

MDA5

CGATCCGAATGATfGATGCA

AGTfGGTCATfGCAACTGCf

TLR3

CTfGCGTfGCGAAGTGAAGAA

CCAATfGTCfGGAAACACCCC

TLR4

TGCACTGAGCfTTAGTGGTfGC

GACCCATGAAATTGGCACTCAT

Oct4

AGTfGGCGTGGAGACTITGC

CAGGGCTITCATGTCCfGG

Nanog

TfGCTfACAAGGGTCTGCTACT

ACTGGTAGAAGAATCAGGGTC

Sox2

GACAGCTACGCGCACATGA

GGTGCATCGGTTGCATCTG

PKR

AAGCAGGAGGCAAGAAACG

TGACAATCCACCTfGTfTTCGT

ISG15

AGGTCTITCfGACGCAGACTG

GGGGCTITAGGCCATACTCC

IFNAR

GACAACTACACCCTAAAGTGGAG

GCTCfGACACGAAACTGTGTfTT

Protein Analysis by Flow Cytometry
To determine the protein level by fluorescence labeling, treated cells were
released by 0.25 % Trypsin-EDTA (GIBCO, Grand Island, NY) and fixed with 80%
ethanol for 30 minutes at 4°C, then washed with PBS that contains 2% bovine serum
albumin (BSA) (Sigma-Aldrich, St. Louis, MO) for 20 minutes. Cells were incubated
with primary antibodies (ICAMl) (Santa Cruz Biotechnology, Inc. , Santa Cruze, CA) at
1: 100 dilution in PBS containing 2% BSA for 2 h at room temperature. The cells were
then incubated with secondary antibodies conjugated with FITC (1 :100) (Santa Cruz
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Biotechnology, Inc., Santa Cruze, CA) in PBS with 2% BSA for 1 hat room temperature.
The cell suspension was examined through an Accuri C6 flow cytometer. The
fluorescence intensity, which correlates with the protein level, was determined with
CFlow software (BD Accuri Cytometers, Inc., Ann Arbor, Ml).
IFNP and Cytokine Assay

The culture medium collected from treated cells was used to determine secreted
IFNP and cytokines. IFNP was quantified with an Enzyme-lined Immune Sorbent Assay

(ELISA) kit (PBL interferon source, Piscataway, NJ) that detects mouse IFNP according
to the manufacturer's instruction. IL6 was analyzed with a Luminex cytokine assay kit
(EMD Millipore Corporation, Billerica, MA) and determined with a MAGPIX instrument
(EMD Millipore Corporation, Billerica, MA). The data was analyzed according to the
method described by Parbhakar et al. (Prabhakar, Eirikis, & Davis, 2002).
Plaque Assay
Titers of LACV in culture medium collected from infected cells were determined
in vero cells by plaque assay as described by Bai et al (Bai et al., 2005). Briefly, 95-100%
confluent vero cells were infected with lOOOOx dilution of culture medium collected from
infected cells and incubated at 37°C in 5% CO2 incubator for lh. After virus adsorption,
medium was removed completely and cells were overlaid with DMEM-agarose and
further incubated for 4 days. The plaques were counted after staining with second overlay
containing 4% (vol/vol) neutral red.
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CHAPTERIY
RESULTS
In order to determine the antiviral responses in mESCs, we treated the cells with

two commonly used two agents. Poly(I:C) is a synthetic double-stranded RNA used as a
viral analog. In many publications, poly(I:C) has been shown to activate antiviral
responses via binding to RIG-I, MDA5, TLR3, and PKR (Heim, 2005; Hu et al., 2011;
Zimmer, 2011). It has also been reported that poly(I:C) can cause cell cycle interruption
via PKR-induced eIF2a phosphorylation, which results in protein synthesis inhibition
(Garcia, Meurs, & Esteban, 2007). LACY belongs to Bunyaviridae family, which can
cause encephalitis. The LACY genome is composed of three single-stranded, negativesense RNA segments. Although poly(I:C) is commonly used to mimic a viral infection, it
is a synthetic compound which may not reflect antiviral response of ESCs under the
physiological conditions. Therefore, LACY, a live virus, is chosen for this study since it
is known to cause lytic cell death of mammalian cells (Yerbruggen et al., 2011). It has
been shown that LACY can activate PKR and induce eIF2a phosphorylation in
fibroblasts (Streitenfeld et al., 2003). Additionally, the non-structured protein of LACY
can also induce mitochondrial cytochrome C release and Caspase activation in cell-free
extracts and promote neuronal apoptosis and mortality in a mouse model (Colon-Ramos
et al., 2003).
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Double Stranded RNA (dsRNA) Transfected to Mouse ESCs (mESCs) Inhibits Cell
Proliferation
We transfected poly(l:C) into mESCs since this is a commonly approach that
induce antiviral responses in many cell types. The most notable effect of transfected
poly(l:C) on mESCs at the cellular level was the inhibition of cell proliferation. As
shown in Fig. 4A, the colonies of poly (I:C)-transfected cells were much smaller than the
control colonies as determined by microscopic analysis (Fig. 4A), correlating with
markedly reduced cell numbers determined by toluidine blue cell staining (Fig. 4B, left
panel). The proliferation inhibition effect of transfected poly(l:C) was also found in
C3HI0Tl/2 cells (Fig. 4B, right panel).
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Figure 4. Effects of poly(I:C) on mESC colony formation and cell proliferation. A and B)
Cells were transfected with 300 ng/mL poly(I:C). Control (Con) represents cells
transfected with DharmaFECT without poly(I:C). A) After incubation for 40h, the
colonies were examined under a phase contrast microscope and photographed with a
digital camera (lOOx, upper panels; 400x, lower panels). B) Cell proliferation was
measured by cell number indirectly determined from toluidine blue staining (absorbance
at 630 nm). The values are means ± SD of an experiment performed in biological
triplicate (B).
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mESCs Fail to Express and Produce IFNP, IL-6, and ICAMl in Response to dsRNA
We analyzed the mRNA levels of IFNP, intercellular adhesion molecule 1
(ICAMl), and proinflammatory cytokine gene such as Interleukin-6 (IL-6) in the cells
transfected with poly(l:C). The mRNA levels of IL-6 and IFNP were negligible in
mESCs compared with C3H10Tl/2 cells (Fig. 5A and B). When examined at the protein
level by ELISA and Luminex assay, neither IFN~ nor IL-6 was detected in the medium
collected from poly(l:C)-transfected mESCs, whereas they were readily detectable in the
samples from C3H10Tl/2 cell cultures (Fig. 5D). Similarly, poly(I:C) can significantly
induce expression of ICAMl in C3H10Tl/2 cells, but not in mESCs (Fig. 5C).
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Figure 5. mESCs fail to express and produce IFNP, IL-6, and ICAMl in response to
dsRNA. A-D, D3 mESCs and C3H10Tl/2 cells were treated with 300 ng/mL poly(l:C).
A and B), mRNA levels ohested genes were analyzed by RT-qPCR. The results are
expressed as fold-activation where the mRNA level in control cells is designated as 1.
The results are means ± SD of three independent experiments. C) Expression profiles of
ICAMl proteins in D3 mESCs and C3H10Tl/2 cells were determined by flow cytometry.
The representative experiments in all panels were repeated at least twice with similar
results. D) The culture medium collected at different time points was analyzed for IFNP
by ELISA (detectable range 15.6-1000 pg/mL) and IL-6 by Luminex assay (detectable
range 0.64-10000 pg/mL). ND: not detected. The values for IFNP are means ± SD of a
representative experiment performed in triplicate. The values for IL-6 are average of a
representative experiment performed in duplicate.
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Relative Expression Levels of dsRNA Receptors in mESCs and C3H10Tl/2 Cells
Innate antiviral responses are mediated by PRRs. These receptors induce the
expression of IL-6 and IFNP by activating the transcription factors IRFs and NF-KB
(Carty & Bowie, 2010; Matsumiya & Stafforini, 2010; Yoneyama & Fujita, 2007).
Therefore, we analyzed the basal mRNA levels of PRR genes. Among the genes we
tested, RIGI, MDA5 are viral dsRNA receptors which are expressed in the cytosol. TLR3
is another viral dsRNA receptor, but it can express both on cell surface and in cytosol.
We observed that they are much lower in mESCs than in C3H10Tl/2 cells (Fig. 6). This
observation indicated that the negligible gene expression of IL-6 and IFNP in mESCs
may be related to the low expression of PRRs.
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Figure 6. The expression levels of RNA receptor genes in mESCs are much lower than in
C3H10Tl/2 cells. Cells were plated at 30-40% confluence and cultured for 24h without
treatment. The mRNA levels of tested genes were analyzed by RT-qPCR. The results are
means ± SD of three independent experiments.
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mESCs Are Susceptible to The Cytopathic Effects of LACY Infection
While poly(I:C) has been used as a dsRNA viral analog (Offermann et al., 1995),
it is an synthesized RNA that does not have biological activities associated with viral
infection. To investigate the responsiveness of mESCs to live viral infection, we used
LACY, a negative sense, single stranded RNA virus, to determine whether mESCs can
respond to live viruses. Because the proliferation of mESCs is much faster than
C3H10Tl/2 cells, mltiplicity of infection (M.O.I) of 10 and 1 were used in mESCs and
C3H10Tl/2, respectively, in LACY infection experiments. The cell number was then
measured by spectrophototmetry where optical density is proportional to cell number.
Our results demonstrated that the LACY challenge reduced the cell viability of mESCs
and C3Hl0Tl/2 cells (Fig. 7A and B), which was due to LACY-induced cytopathic
effect (Fig. 7C). The viral infection of mESCs was confirmed by the expression of a
LACY gene that encodes an M-segment protein (Ge protein) (Soldan, Hollidge, Wagner,
Weber, & Gonzalez-Scarano, 2010). The infected cells were immunostained with
monoclonal antibodies against the Ge protein (a gift from Dr. Samantha Soldan,
University of Pennsylvania School of Medicine) followed by flow cytometry analysis. As
shown in Fig. 7D, the expression of Ge protein was detected at 30 h and was significantly
increased at 40 h post infection.
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Figure 7. mESCs are susceptible to the cytopathic effects of LACV infection. A and B)
D3 mESCs and C3H10Tl/2 cells were infected with LACV at M.0.1=10 and M.0.1=1,
respectively, for 48h. Viable cells were determined at 48 h post infection by toluidine
blue staining. The values for D3 mESCs are means ± SD of three independent
experiments, while the value for C3H10Tl/2 cells is representative experiment performed
three times. C) D3 mESCs and C3Hl0Tl/2 cells were infected with LACV (M.0.1=1).
The cells were examined under a phase contrast microscope and photographed (400 x) at
48 h for C3H10Tl/2 cells and 60 h for D3 cells. Arrows denote detaching dead cells. D)
Detection of LACV Ge protein in D3 cells infected with LACV (MOI=lO) by flow
cytometry. All experiments were performed at least twice with similar results.
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mESCs Are Deficient in Expressing Type I IFN in Response to Viral Infection
In order to address the question of whether or not a live virus can induce antiviral

responses in mESCs, we infected mESCs and C3HI0T1/2 cells with LACY and analyzed
the mRNA levels of antiviral genes. Even at very high M.O.I. (10), LACY only induced
the negligible expression of type I IFNs in mESCs, but the induction in C3HI0T1/2 cells
is drastic (Fig. 8).
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Figure 8. mESCs are deficient in expressing type I IFN in response to viral infection. D3
mESCs and C3H10Tl/2 cells were infected with LACY at M.0.1=10 and M.0.I.=1,
respectively. The mRNA levels of the tested genes were determined by RT-qPCR 24 h
post-infection. The results are means± SD of three independent experiments.
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IFNP Inhibits LACV Replication and Protects mESCs from LACY-Induced Cytopathic
Effects
It is clear that the mESCs are deficient in IFN expression in response to viral

infection and dsRNA. Since the expression of IFN and responsiveness to IFN are through
different signaling pathways (as illustrated in Fig.2 and Fig.3). It would be interesting to
see if mESCs can respond to IFN. We pretreated ESCs with IFNP followed by LACV
infection. As shown in Fig. 9A, IFNP pretreatment protected mESCs from LACV
induced cell death as judged by the increased number of viable cells after infection (Fig.
9A). Furthermore, the result of LACV viral titer analysis indicated that IFNP treatment
can significantly inhibit LACV replication in mESCs as judged by the reduced viral titer
(Fig. 9B).
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Figure 9. IFNP can protect mESCs from LACY-induced lytic cell death. A) D3 mESCs
were pre-treated with IFNP (5000U/mL) for 24h. Then, the pretreated cells were infected
with LACV at M.0.1=10 for 48h. Viable cells were determined at 48 h post infection by
toluidine blue staining. B) The culture medium collected at 48 h post infection was
analyzed for viral titer by plaque assay. The values are means± SD of three independent
experiments.
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IFNP Induces the Expression of dsRNA Receptors and Interferon-Stimulated Genes in
mESCs
To determine IFNP-induced cellular responses, we analyzed the expression level
of type I IFN receptors (IFNARl) and genes that are known to be regulated by IFNP. As
indicated in the Fig. lOA, IFNARl was readily detected at the mRNA level in mESC
although it is lower than in C3H10Tl/2 cells. The mRNA levels of viral RNA receptors,
including RIG-I, MDA5 and TLR3, were increased by IFNP treatment (Fig. 10B).
Finally, we analyzed the expression of IFN~-stimulated gene 15 (ISG15), which was
upregulated about 80 fold. Together, the results from these experiments confirm that
mESCs are responsive to IFNP and that the signaling pathways that mediate the effects of
IFNP are functional.
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Figure 10. IFN~ induces the expression of dsRNA receptors and ISGs in mESCs. A) D3
mESCs were plated at 30-40% confluence and cultured for 24 h without treatment. B and
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CHAPTER V
DISCUSSION
In this study, we investigated the responses of mESC to a viral dsRNA analog and

to live La Crosse Virus (LACV) infection. While both stimuli induced a robust IFNa/p
expression in C3H10Tl/2 cells, they only induced very limited or no detectable
transcription of IFNa/P in mESCs. These results suggest that mESCs are deficient in type
I IFN expression, a central component of antiviral mechanisms in most types of somatic
cells.
We have found that the defective IFNa/P expression in mESCs could be
explained by the low expression level of TLR3 although we could not rule out other
mechanisms that may be involved. In some cell types, poly(l:C) can induce IFN via
activation of TLR3 at the cell surface or in the endosomes (Stetson & Medzhitov, 2006;
Meylan & Tschopp, 2006; Nasirudeen et al. , 2011). When transfected into the cells,
poly(I:C) can induce robust IFN expression and other responses that are similar to those
evoked by viral infection via cytoplasmic dsRNA receptors (Fortier et al., 2004;
Matsumoto & Seya, 2008). mESCs were unresponsive to poly(I:C) that was directly
added to the medium, likely due to the very low expression level of TLR3. However,
poly(I:C) transfected into the mESCs showed a profound inhibitory effect on
proliferation, a known effect of polyIC on many types of differentiated cells, indicating
that the cytoplasmic receptors for poly(l:C) are active in mESCs. While we have
provided substantial amount of evidence that poly(I:C) induced PKR activation is
responsible for cell inhibition of ESCs, it is clear that the mechanisms mediating type I
IFN is not functional in mESCs (Wang et al. , 2013).
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It is generally believed that MDA5 and RIG-I play primary roles in mediating

viral RNA induced IFNa/p expression in the cytoplasm (Stetson & Medzhitov, 2006;
Nasirudeen et al., 2011), while PKR also contributes to and modulates this process
(Garcia, Meurs, & Esteban, 2007; Samuel, 2001). Since MDA5 is expressed at negligible
level in mESCs, it is conceivable that PKR and/or RIG-I may mediate the effects of
transfected poly(I:C). However, the RIG-I signaling pathway seems to be inactive since
silencing RIG-I did not affect the effects of polyIC and that 3p-ssRNA (5'-triphosphate
single- stranded RNA), the best studied ligands of RIG-I (Pichlmair, et al., 2006;
Yoneyama & Fujita, 2007), failed to induce IFN in mESCs (unpublished data).
It was reported that LACY has developed certain mechanism to avoid the host
innate antiviral responses. Repressing IFNa/P induction in host cells is one of such
mechanisms (Haller, Kochs, & Weber, 2006). However, the capacity of LACY to repress
IFNa/p induction seems to depend on the types of host cells, as we demonstrated in
C3H10Tl/2 cells in which LACY can induce strong transcription of IFNP, but not in
mESCs. The similar results were also found in dsRNA viral analog, West Nile Virus
(WNV), and Sendai Virus (SeV) treated C3Hl0Tl/2 and mESCs (data not shown). It
seems that the failure to express IFNa/P in mESCs could be an intrinsic property of
mESCs, even though they are sensitive to the cytopathic effect of LACY infection. This
conclusion is in line with similar observations, recently reported by Wash et al (Wash,
Calabressi, Franz, Griffiths, & Goulding, 2012), that herpes simplex virus (HSV) and
influenza virus (a negative sense, ssRNA virus) caused cytopathic effects without
evoking type I IFN in mESCs.
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The antiviral responses include two major types of cellular responses: pathogen
recognition/IFN production and IFN positive feedback regulation (Takaoka & Yanai,
2006). The best known function of type I IFN is their antiviral responses. In
differentiated cells, IFN can enhance the antiviral responses of the cells by induction of
several genes, known as IFN-stimulated genes (ISGs), which participate in various stages
of antiviral responses. It is intriguing to find that mESCs do not have functional
mechanism to synthesis IFN, yet they can respond IFN as demonstrated by the expression
of the type I IFN receptor, expression of ISGs, and IFNP-priming induced protection
mESCs from LACY-induced cytopathic effects. These observations support a conclusion
that mESCs have functional mechanisms to detect and respond to IFNP although the
cellular and molecular mechanisms involved remain to be investigated.
In summary, our study demonstrates that expression of type I IFN, a crucial part
of antiviral responses, is underdeveloped in mESCs, but the IFNP receiving and
responding mechanisms are functional. This study may open up an important area in ESC
research for understanding the development of antiviral mechanisms during
embryogenesis and how the immunogenic signals affects ESC physiology.
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